The present invention relates to valacyclovir formulations having improved bioavailability resulting in better efficacy and/or requiring less frequent administration.
本发明涉及瓦拉西韦制剂,其具有改善的生物利用度,从而具有更好的疗效和/或需要更少的频繁给药。
Compositions for delivering peptide YY and PYY agonists
申请人:Dinh Steve
公开号:US20050009748A1
公开(公告)日:2005-01-13
The present invention provides a composition (e.g., a pharmaceutical composition) comprising at least one delivery agent compound and at least one of peptide YY (PYY) and a PYY agonist. Preferably, the composition includes a therapeutically effective amount of peptide YY or the PYY agonist and the delivery agent compound. The composition of the present invention facilitates the delivery of PYY, a PYY agonist, or a mixture thereof and increases its bioavailability compared to administration without the delivery agent compound. PPY and PYY agonists possess activity as agents to reduce nutrient availability, including reduction of food intake